Literature DB >> 28834474

Adjuvant Capecitabine for Breast Cancer.

Masakazu Toi1, Norikazu Masuda2, Yasuo Ohashi3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28834474     DOI： 10.1056/NEJMc1708487

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  6 in total

1.  Conflict of Interest and the CREATE-X Trial in the New England Journal of Medicine.

Authors:  Akihiko Ozaki
Journal:  Sci Eng Ethics       Date:  2017-09-15       Impact factor: 3.525

2.  A call for improved transparency in financial aspects of clinical trials: a case study of the CREATE-X trial in the New England Journal of Medicine.

Authors:  Akihiko Ozaki; Morihito Takita; Tetsuya Tanimoto
Journal:  Invest New Drugs       Date:  2018-03-08       Impact factor: 3.850

Review 3.  Breast cancer in 2017: Spurring science, marking progress, and influencing history.

Authors:  Jose Perez-Garcia; Javier Cortes
Journal:  Nat Rev Clin Oncol       Date:  2017-12-12       Impact factor: 66.675

4.  A non-toxic approach for treatment of breast cancer and its metastases: capecitabine enhanced photodynamic therapy in a murine breast tumor model.

Authors:  Sanjay Anand; Anton Yasinchak; Taylor Bullock; Mukul Govande; Edward V Maytin
Journal:  J Cancer Metastasis Treat       Date:  2019-01-24

5.  Changes in Triple-Negative Breast Cancer Molecular Subtypes in Patients Without Pathologic Complete Response After Neoadjuvant Systemic Chemotherapy.

Authors:  Hiroko Masuda; Kenichi Harano; Sakiko Miura; Ying Wang; Yuko Hirota; Oi Harada; Mohit Kumar Jolly; Yuki Matsunaga; Bora Lim; Anita L Wood; Napa Parinyanitikul; Hee Jin Lee; Gyungyub Gong; Jason T George; Herbert Levine; Jangsoon Lee; Xiaoping Wang; Anthony Lucci; Arvind Rao; Brock L Schweitzer; O Rayne Lawrence; Robert S Seitz; Stephan W Morris; David R Hout; Seigo Nakamura; Savitri Krishnamurthy; Naoto T Ueno
Journal:  JCO Precis Oncol       Date:  2022-03

6.  A progressive and refractory case of breast cancer with Cowden syndrome.

Authors:  Aiko Sueta; Masako Takeno; Lisa Goto-Yamaguchi; Mai Tomiguchi; Toko Inao; Mutsuko Yamamoto-Ibusuki; Yutaka Yamamoto
Journal:  World J Surg Oncol       Date:  2022-09-03       Impact factor: 3.253
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.